ARTICLE
TITLE

A combinatorial anti-CTLA antibody and radiation therapy on metastatic lung cancer

SUMMARY

Cytotoxic T-lymphocyte antigen 4 (CTLA-4) is an inhibitory receptor that regulates T-cell activation and transmits signals that suppress T-cell activation and proliferation through the depletion of CD8+ T cells.  Antibodies targeting CTLA-4 can selectively deplete regulatory T cells by antibody-mediated cellular cytotoxicity mechanisms. However, CTLA-4 as a single treatment is not effective for against immunogenic diseases like metastatic cancers. Radiation therapy (RT) on the other hand is a longstanding pillar of cancer treatment, historically utilized to treat a discrete target and provide local tumor control. Recent studies demonstrated that RT is synergistic with anti-CTLA antibody and enhanced systemic anti-tumor responses. In order to better understand the effect of the combination therapy, we developed an impulsive ODE model to describe the interaction between tumor cells and the immune system. The model variables were coupled with published experimental data. The objective of this study was to develop a predictive simulation platform to improve cancer management by manipulating dose and fractionation schedule of the combination therapy. This project is supported by NIH Grant P20GM103434 to the West Virginia IDeA Network for Biomedical Research Excellence.

KEYWORDS

 Articles related

Aaron Kessler,Bruce Anthony    

Fetal Alcohol Spectrum Disorders (FASD) are a set of developmental disorders that come to those born from mothers who drink alcohol during gestation. Phenotypes are associated with alterations in proliferation, differentiation, migration and apoptosis of... see more


Ashley D Moore,Supriya Shrestha,Gerald R Hankins    

Glioblastomas are almost invariably fatal brain tumors. Glioblastoma incidence in men is 1.5 times that of pre-menopausal women and this difference decreases post-menopause. Therefore estrogen is thought to play a protective role, although the mechanism ... see more


A. N. Belousov, E. I. Malygon, T. O. Kalynychenko, E. Y. Belousova, V. V. Yavorskiy, M. Y. Anoshyna    

Currently, the use of nanotechnology opens up new opportunities to influence the processes of anaerobic glycolysis and the activity of hexose monophosphate reactions in preserved erythrocytes. Components containing donor red blood cells on CPDA-1 preserv... see more


D. Michalski, M. Heindl, J. Kacza, F. Laignel, L. Küppers-Tiedt, D. Schneider, J. Grosche, J. Boltze, M. Löhr, C. Hobohm, W. Härtig    

Inflammation following ischaemic stroke attracts high priority in current research, particularly using human-like models and long-term observation periods considering translational aspects. The present study aimed on the spatio-temporal course of macroph... see more


Zhixiong Wang, Qian Liu, Na Risu, Jiayu Fu, Yan Zou, Jiaxing Tang, Long Li, Hui Liu, Guomin Zhou, Xuekai Zhu    

Chimeric antigen receptor (CAR) T cell therapy still faces the challenge of immunosuppression when treating solid tumors. TGF-ß is one of the critical factors in the tumor microenvironment to help tumors escape surveillance by the immune system. Here we ... see more